CX3CR1 is a chemokine receptor that, by influencing monocyte chemotaxis and tumor angiogenesis (Pawelec et al., 2020), can alter the tumor immune microenvironment, thereby affecting tumor development and immune responses (Schmall et al., 2015). This evidence concerns the gene CX3CR1 and neoplasm.